# Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma

> **NCT00172367** · PHASE2 · WITHDRAWN · sponsor: **National Taiwan University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Carcinoma, Transitional Cell

## Interventions

- **DRUG:** Lycopene

## Key facts

- **NCT ID:** NCT00172367
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** This study was for National Science Council project. The study was not funded, so the study was withdrawn.
- **Last updated:** 2008-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00172367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00172367, "Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00172367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*